The Slow Newscast The immortality bros: the new frontiers of health
13 snips
Sep 9, 2025 In a city in Honduras, a start-up is selling experimental gene therapies for $25,000 a dose, sparking discussions on the future of healthcare. The intriguing mix of radical health treatments and libertarian ideals is making its way to the U.S. The conversation dives into Jim O'Neill's vision for patient empowerment and controversial reforms to the FDA. Listeners hear about thrilling seasteading escapades and legal battles, alongside the ethical dilemmas surrounding unproven longevity treatments and expanding right-to-try laws in Montana.
AI Snips
Chapters
Transcript
Episode notes
Seasteaders Flee After Thai Raid
- Chad and Nadia lived on a seastead off the coast of Thailand and became fugitives when authorities moved against them.
- Their experiment shows how living beyond state control can quickly collide with national law and danger.
Seasteading Moves Onshore To Charter Cities
- Patry Friedman pivoted seasteading from ocean platforms to onshore charter cities called Prospera.
- These zones promise new rules and autonomy to attract entrepreneurs and medical companies.
Founder Took Experimental Gene Treatments
- Patry Friedman personally received multiple experimental procedures in Prospera, including follistatin gene therapy.
- He described signing forms warning treatments had not been evaluated by the U.S. Food and Drug Administration.